Most bought healthcare stocks in Q3 2021
See which Healthcare stocks institutional investors increased the most in Q3 2021, measured as net growth in reported share positions from Q2 2021 into Q3 2021. Notable additions at the top of this list include SANOFI-ADR (SNY), WARBY PARKER INC-CLASS A (WRBY), QUANTUM-SI INC (QSI), GILEAD SCIENCES INC (GILD). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| SNY | SANOFI-ADR | 23,792,944 | $833.21M | 0 | 3 | 2 | 1 | 6 |
| WRBY | WARBY PARKER INC-CLASS A | 23,020,206 | $1.22B | 2 | 0 | 0 | 0 | 2 |
| QSI | QUANTUM-SI INC | 8,650,078 | $56.27M | 0 | 1 | 0 | 0 | 1 |
| GILD | GILEAD SCIENCES INC | 8,530,311 | $659.16M | 0 | 10 | 3 | 1 | 13 |
| PFE | PFIZER INC | 7,168,709 | $455.79M | 1 | 7 | 9 | 1 | 20 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 6,843,645 | $415.12M | 2 | 3 | 2 | 1 | 7 |
| FMS | FRESENIUS MEDICAL CARE-ADR | 6,652,628 | $228.82M | 1 | 2 | 0 | 0 | 3 |
| NVS | NOVARTIS AG-SPONSORED ADR | 5,830,706 | $214.41M | 0 | 3 | 6 | 2 | 10 |
| PRCT | PROCEPT BIOROBOTICS CORP | 5,507,892 | $210.13M | 2 | 0 | 0 | 0 | 2 |
| RLYB | RALLYBIO CORP | 4,194,777 | $73.74M | 1 | 0 | 0 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | 3,840,339 | -$25.31M | 0 | 3 | 0 | 1 | 3 |
| CI | THE CIGNA GROUP | 3,342,846 | $85.22M | 0 | 5 | 3 | 1 | 9 |
| ELAN | ELANCO ANIMAL HEALTH INC | 3,278,313 | $91.47M | 2 | 2 | 3 | 0 | 7 |
| INCY | INCYTE CORP | 2,655,304 | -$140.80M | 0 | 2 | 5 | 0 | 7 |
| HUM | HUMANA INC | 2,502,061 | $940.66M | 1 | 4 | 1 | 0 | 7 |
| OSCR | OSCAR HEALTH INC - CLASS A | 2,445,147 | $16.90M | 1 | 2 | 0 | 0 | 3 |
| AVIR | ATEA PHARMACEUTICALS INC | 1,677,487 | $58.82M | 2 | 0 | 1 | 0 | 3 |
| SENS | SENSEONICS HOLDINGS INC | 1,676,173 | $3.10M | 0 | 1 | 0 | 0 | 1 |
| ZLAB | ZAI LAB LTD-ADR | 1,649,899 | $60.88M | 1 | 1 | 0 | 0 | 3 |
| NUVL | NUVALENT INC-A | 1,647,671 | $37.16M | 1 | 0 | 0 | 0 | 1 |
| JNJ | JOHNSON & JOHNSON | 1,437,791 | $197.58M | 2 | 8 | 9 | 3 | 25 |
| THC | TENET HEALTHCARE CORP | 1,074,674 | $70.15M | 0 | 1 | 0 | 0 | 1 |
| EXAS | EXACT SCIENCES CORP | 1,018,568 | -$213.20M | 0 | 4 | 1 | 0 | 5 |
| BLRX | BIOLINERX LTD-SPONS ADR | 1,013,105 | $2.78M | 1 | 0 | 1 | 0 | 2 |
| RPTX | REPARE THERAPEUTICS INC | 935,979 | $14.45M | 0 | 1 | 1 | 0 | 2 |
| AHCO | ADAPTHEALTH CORP | 914,096 | $8.26M | 1 | 1 | 0 | 1 | 2 |
| LLY | ELI LILLY & CO | 903,983 | $234.05M | 0 | 4 | 6 | 1 | 11 |
| CARA | CARA THERAPEUTICS INC | 837,783 | $13.92M | 0 | 1 | 0 | 1 | 1 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 774,285 | -$46.69M | 0 | 3 | 4 | 0 | 8 |
| PPBT | PURPLE BIOTECH LTD-ADR | 736,019 | $3.37M | 1 | 0 | 0 | 0 | 1 |
| VERV | VERVE THERAPEUTICS INC | 719,316 | $26.54M | 0 | 1 | 0 | 0 | 1 |
| OPCH | OPTION CARE HEALTH INC | 704,419 | $19.10M | 1 | 3 | 0 | 0 | 4 |
| BAX | BAXTER INTERNATIONAL INC | 653,182 | $54.64M | 1 | 5 | 2 | 2 | 11 |
| GH | GUARDANT HEALTH INC | 640,252 | $83.53M | 0 | 2 | 0 | 0 | 3 |
| ILMN | ILLUMINA INC | 626,652 | $70.51M | 2 | 3 | 4 | 0 | 9 |
| DH | DEFINITIVE HEALTHCARE CORP | 600,000 | $25.70M | 1 | 0 | 0 | 0 | 1 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 587,172 | $18.63M | 1 | 8 | 3 | 2 | 12 |
| CLDX | CELLDEX THERAPEUTICS INC | 559,545 | $37.69M | 1 | 0 | 1 | 0 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 546,818 | $50.78M | 0 | 2 | 0 | 0 | 3 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 487,944 | -$219.52M | 0 | 1 | 1 | 0 | 3 |
| INMD | INMODE LTD SHS | 478,379 | $122.49M | 2 | 4 | 0 | 0 | 6 |
| KPTI | KARYOPHARM THERAPEUTICS INC | 476,928 | $2.69M | 0 | 1 | 0 | 0 | 1 |
| DGX | QUEST DIAGNOSTICS INC | 475,214 | $85.46M | 0 | 3 | 2 | 1 | 6 |
| RXRX | RECURSION PHARMACEUTICALS-A | 475,102 | -$21.16M | 1 | 1 | 0 | 0 | 2 |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 464,577 | $8.94M | 1 | 0 | 1 | 0 | 2 |
| TDOC | TELADOC HEALTH INC | 443,785 | -$582.85M | 0 | 4 | 2 | 1 | 6 |
| ELV | ELEVANCE HEALTH INC | 429,594 | $77.54M | 2 | 6 | 5 | 1 | 15 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 420,930 | -$201.92M | 0 | 1 | 1 | 1 | 3 |
| BEAM | BEAM THERAPEUTICS INC | 363,755 | -$238.48M | 0 | 1 | 0 | 2 | 1 |
| TALK | TALKSPACE INC | 359,923 | $1.21M | 1 | 0 | 1 | 0 | 2 |
Frequently asked questions about Most bought healthcare stocks in Q3 2021
What are the most bought Healthcare stocks in Q3 2021?
The most bought healthcare stocks in Q3 2021 are those with the largest increase in reported share counts across institutional investors compared to Q2 2021, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2021?
Among filers in this sector, net additions were largest in companies such as SANOFI-ADR (SNY), WARBY PARKER INC-CLASS A (WRBY), QUANTUM-SI INC (QSI), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2021).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.